| Development and evaluation of combined cancer screening strategies for high-risk populations of Prostate, Lung, Colorectal and Ovarian Cancers |
Huang Yubei |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Jan 13, 2022 |
PLCO-895 |
| Threshold quantile regression models with applications to PSA data |
Eun Ryung Lee |
Sungkyunkwan University |
PLCO |
Jan 7, 2022 |
PLCO-893 |
| Modeling risk for lung cancer using trans-ancestry polygenic risk score, blood biomarkers, and lifestyle behaviors |
Meng Zhu |
Nanjing Medical University |
PLCO |
Jan 7, 2022 |
PLCO-892 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
Percy Guzman |
PLCO |
Jan 7, 2022 |
PLCO-882 |
| Chest Radiograph And Pathologic Phenotype For Biological Age Prediction Using Deep Learning – Training and Validation in Chinese Patients |
Varut Vardhanabhuti |
The University of Hong Kong |
PLCO |
Jan 5, 2022 |
PLCOI-820 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| Development of deep learning frameworks based on pathology images for biomarker development |
Jennifer Beane |
Trustees of Boston University |
PLCO |
Jan 5, 2022 |
PLCOI-881 |
| The impact of hormone replacement therapy on cancer |
Zhaoyu Li |
University of Western Australia |
PLCO |
Dec 30, 2021 |
PLCO-883 |
| Meta-analysis of 16S head and neck cancer |
Kenny Yeo |
University of Adelaide |
PLCO |
Dec 14, 2021 |
PLCO-879 |
| Detection of prostate cancer using machine learning techniques: An exploratory study |
Laxmi Manasa Gorugantu |
Dakota State University |
PLCO |
Dec 13, 2021 |
PLCO-873 |
| Reproducibility and external validation of epidemiological risk models for endometrial cancer |
Aline Talhouk |
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada |
PLCO |
Dec 13, 2021 |
PLCO-878 |
| Breast cancer prognosis |
Lee Cooper |
Northwestern University |
PLCO |
Dec 13, 2021 |
PLCOI-877 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification |
Eric Li |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 10, 2021 |
PLCOI-876 |
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO |
Hormuzd Katki |
NCI |
PLCO |
Dec 8, 2021 |
PLCO-875 |
| Using PRS for CRC screening |
Ulrike Peters |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 8, 2021 |
PLCO-872 |
| Instrumental Variable Estimation of Complier Causal Treatment Effect with Interval-Censored Data |
Jianguo Sun |
University of Missouri-Columbia |
PLCO |
Nov 30, 2021 |
PLCO-871 |
| Identifying risk factors for colorectal neoplasia through machine learning |
Daniella Araujo |
Universidade Federal de Minas Gerais |
PLCO |
Nov 30, 2021 |
PLCO-870 |
| Melanoma Comorbidity Clusters |
Vishnutheertha Kulkarni |
Johns Hopkins University |
PLCO |
Nov 30, 2021 |
PLCO-869 |
| Exploring prognostic value of tumor infiltrating lymphocytes (TILs) in multiple cancer types |
Shuoyu Xu |
Bio-totem Pte Ltd |
PLCO |
Nov 22, 2021 |
PLCOI-862 |
| Combining Classifier with Bagging for endometriosis prediction. |
David Kilembwe |
Independent |
PLCO |
Nov 22, 2021 |
PLCO-861 |
